CompoAtlas

Vitamin D3

Natural health product licensed in Canada

Other names
D3, Vitamin D
Licence holder
Bioclinic Naturals Inc.
NPN or DIN-HM
80111256
Status
Active licence
Licence date
8 July 2021
Revision date
Not provided
Form
Comprimé, désagrégeant oralement
Route of administration
Sublinguale
Application type
Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Vitamine D

Source : Cholécalciférol

62.5 mcg
Vitamine D

Source : Cholécalciférol

2,500 UI

Non-medicinal ingredients

Croscarmellose de sodium, Lactose monohydraté, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to prevent vitamin D deficiency. Vitamin D intake, when combined with sufficient calcium, a healthy diet and regular exercise may reduce the risk of developing osteoporosis in people with vitamin D deficiency.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80111256

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line